Next Generation News and Research

RSS

FDA approves St. Jude Medical's EnSite Velocity Cardiac Mapping System

St. Jude Medical, Inc. (NYSE: STJ) today announced U.S. Food and Drug Administration (FDA) clearance and U.S. launch of its EnSite Velocity™ Cardiac Mapping System. This new system has been designed to help physicians more efficiently diagnose and guide therapy to treat abnormal heart rhythms.

14 Sep 2009

VBI's flu vaccine offers protection against H1N1

Variation Biotechnologies, Inc. (VBI), an emerging leader in the discovery and development of novel vaccines to fight infectious diseases, today reported that the company’s proprietary influenza vaccine triggered a robust immune response and provided protection against the H1N1 strain of influenza.

14 Sep 2009

Titan Medical entitles shareholders to purchase common share at $0.24

Titan Medical Inc. announces that its board of directors has approved the grants of 653,680 options to directors and senior officers of the company and 50,974 options to consultants of the company. Each option entitles its holder to purchase one common share of Titan at a price of $0.24 for a period of five years from the date of grant.

14 Sep 2009

Parkinson Society Canada's SuperWalk raises record amount

SuperWalk for Parkinson's raised a record $2.46 million this year. Lauren Collins, star of Degrassi: The Next Generation, unveiled the new look SuperWalk for 2010 at this year's Toronto walk. Collins, left, walked with her mother, Sari, for her father who has had Parkinson's for over 20 years.

14 Sep 2009

Immigration and education policies to impact United states' leadership in science and discovery

Immigration and education policy experts gathered on Capitol Hill today to address the impact of policies related to U.S. medical innovation. The briefing, titled Education & Immigration: The Building Blocks of Innovation, was sponsored by the Council for American Medical Innovation as the first in a three-part series, Recovery Through Discovery, which examines medical innovation as a driver of U.S. economic recovery and enhanced global leadership in science.

11 Sep 2009

Solta Medical launches new Thermage CPT and Fraxel re:store Dual systems

Solta Medical, Inc. (Nasdaq: SLTM) is proud to celebrate the launch of the new Thermage CPT and Fraxel re:store Dual systems with the kick off of the illumiNATION tour (www.illumiNATIONtour.com). Starting September 14 and continuing through November, the illumiNATION tour is bringing the latest breakthroughs in Thermage(R) and Fraxel(R) systems directly to physicians in over 20 cities across the U.S. and 11 cities in Europe.

11 Sep 2009

HHS Secretary to issue new report on the employer-sponsored insurance market

HHS Secretary Kathleen Sebelius today will address the University of Chicago’s dialogue on health care reform and education and issue a new report on the employer-sponsored insurance market.

11 Sep 2009

MedVentive’s POC platform implemented at Hartford PHO

We are pleased to announce that Hartford PHO has gone live using MedVentive’s advanced clinical registries and sophisticated point of care (POC) decision support platform to help them improve the quality and coordination of patient care, promote efficiency, and support their clinical integration program.

10 Sep 2009

Peer Review Survey 2009 releases its preliminary findings

Peer review is fundamental to integration of new research findings. It allows other researchers to analyse findings and society at large to weigh up research claims. It results in 1.3 million learned articles published every year, and it is growing rapidly with the expansion of the global research community. With that growth come new concerns - about getting the next generation of researchers to review in sufficient numbers, about maintaining the system's integrity and whether it can be truly globalised; and also new ideas - about alternative quality measures, technologies to prevent plagiarism, rewarding reviewers and training them.

9 Sep 2009

Sequoia Hospital completes 1000 atrial fibrillation ablation procedures

Sequoia Hospital announced that the Cardiac Arrhythmia Program has completed 1,000 atrial fibrillation (A-Fib) ablation procedures, making it the highest total volume A-Fib ablation institution currently performing ablations in Northern and Central California.

9 Sep 2009

Neuroprosthetics 2009 national conference to focus on artificial limbs

On September 16, leaders in research and development of implantable limb neuroprosthetics will gather at Worcester Polytechnic Institute (WPI) to discuss the state of the field and to advance collaborations that will push next-generation artificial limbs and prosthetic devices closer to clinical application.

9 Sep 2009

Dr. Terry Collins offers public lecture on the growing field of green chemistry

Consumer concerns over hazardous chemicals in the air and water have led scientists to find solutions in the new field of green chemistry. "The most troubling health effects are associated with endocrine disrupting chemicals (EDCs) that may interfere with cellular development in humans and animals," says Dr. Terry Collins, a champion in the field.

9 Sep 2009

TransIT-2020 transfection reagent released by Mirus Bio

From the transfection experts, Mirus Bio introduces its next generation transfection reagent, TransIT(R)-2020 Transfection Reagent.

9 Sep 2009

Craneware reports 23% increase in revenues in the fiscal year-end results

Craneware, Inc. (AIM: CRW.L), a leader in sustainable financial improvement solutions for the U.S. healthcare market, is pleased to announce results for the year ended June 30, 2009.

9 Sep 2009

RIKEN Yokohama Institute to purchase Genetic Analysis Systems from Helicos BioSciences

Helicos BioSciences Corporation (NASDAQ:HLCS) today announced that the RIKEN Yokohama Institute Omics Science Center (OSC) has agreed to purchase four Helicos™ Genetic Analysis Systems. The transaction represents the first multisystem sale of the Helicos system to a large genome center. Shipments are expected to take place in September, with one system remaining in Cambridge to be used in a scientific collaboration between the two parties that began last year.

8 Sep 2009

rPA anthrax vaccine and its Valortim anthrax anti-toxin program data presented

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that data from the Company's third generation recombinant protective antigen (rPA) anthrax vaccine program and its Valortim((R)) anthrax anti-toxin program were presented at the Bacillus - ACT 2009 meeting, August 30 - September 3, 2009, organized by the American Society for Microbiology.

4 Sep 2009

NSF grants funds to develop next-generation nano-CT imaging system

In 1991, Ge Wang produced the first paper on spiral cone-beam computed tomography (CT), now an imaging technique used in the mainstream of the medical CT field. Today, Wang, known as a pioneer in this field, and his colleagues have been awarded more than $1.3 million from the National Science Foundation (NSF) to develop the next-generation nano-CT imaging system, which promises to greatly reduce the required dose of radiation.

4 Sep 2009

FDA approves new xTAG Cystic Fibrosis 39 Kit v2 from Luminex

Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new cystic fibrosis (CF) test: the xTAG® Cystic Fibrosis 39 Kit v2.

From Thermo Fisher Scientific Inc. 4 Sep 2009

New center to study mathematical modeling of drug resistance and internention to be established at HSPH

A new center that will focus on mathematical modeling of drug resistance, seasonal infectious diseases, and intervention allocation will be established at the Harvard School of Public Health (HSPH).

4 Sep 2009

Neuronetics raises funds to expand sales team for NeuroStar TMS Therapy

New Leaf Venture Partners (NLV Partners) announced today it has led a $30 million Series D financing round in Neuronetics, Inc., maker of NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy® for the treatment of depression.

3 Sep 2009